Acute Lymphocytic Leukemia (ALL) Recruiting Phase 2 Trials for DB06809 (Plerixafor)

Back to Acute Lymphocytic Leukemia (ALL)

Also known as: Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

IndicationStatusPhase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02605460Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete RemissionTreatment